SCHEMBL28523968

SCHEMBL28523968

C#Cc1cnc2[nH]c(=O)[nH]c2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.46
RPS6KA3 P51812 3/20 0.38
TYRO3 Q06418 2/20 0.38
DYRK1B Q9Y463 2/20 0.38
PRKD3 O94806 2/20 0.38
MAP4K4 O95819 2/20 0.38
RET P07949 2/20 0.38
PIM1 P11309 2/20 0.38
KDR P35968 2/20 0.38
GSK3A P49840 2/20 0.38
GSK3B P49841 2/20 0.38
CDK5 Q00535 2/20 0.38
MAP4K2 Q12851 2/20 0.38
AURKB Q96GD4 2/20 0.38
CLK4 Q9HAZ1 2/20 0.38
AURKA O14965 1/20 0.38
DAPK3 O43293 1/20 0.38
JAK2 O60674 1/20 0.38
PAK4 O96013 1/20 0.38
ABL1 P00519 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28521892 0.75 TYRO3 (0.34) CYP1A2RPS6KA3TYRO3DYRK1BPRKD3
SCHEMBL1219980 0.74 TYRO3 (0.50) RPS6KA3TYRO3DYRK1BPRKD3MAP4K4
SCHEMBL20075992 0.72 CYP1A2 (0.42) CYP1A2PDE3BPDE3A
SCHEMBL15915542 0.71 RET (0.52) RPS6KA3TYRO3DYRK1BPRKD3MAP4K4
SCHEMBL30328922 0.71 RET (0.52) RPS6KA3TYRO3DYRK1BPRKD3MAP4K4
SCHEMBL4406429 0.69 CDK5 (0.42) CYP1A2RPS6KA3TYRO3DYRK1BPRKD3
SCHEMBL28529536 0.69 CYP1A2 (0.63) CYP1A2KDM4EALDH1A1GAAPDE3B
SCHEMBL979601 0.67 CYP1A2 (0.38) CYP1A2
SCHEMBL650127 0.65 MAPK1 (0.56) CYP1A2JAK2CDK8
SCHEMBL18238553 0.65 RPS6KA3 (0.38) CYP1A2RPS6KA3TYRO3DYRK1BPRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108473476-B Alkynyl heterocyclic compounds for inhibiting protein kinase activity 深圳市塔吉瑞生物医药有限公司 2021-02-19 CN disclosed